Erleada (apalutamide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Erleada (apalutamide), covering 2025-07-30 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. [Phase 3]